← Contracts
PT
Aquisição de Anagrelida 0.5 mg cáps, Lenvatinib 4 mg cáps (LENVIMA), Tacrolímus 1 mg pó susp oral SAQ e Trastuzumab emtansina 160 mg pó conc sol inj fr IV
ID 12199382
· Portal BASE
Price
Base Price
€255,150
.00
Effective Price
€2,700
.00
-98.9%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
TEVA PHARMA - PRODUTOS FARMACÊUTICOS LDA
NIF 507045491
Dates
- Publication
- 26 Dec 2025
- Celebration
- 23 Dec 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 255150.0
- Total effective price
- 2700.0
- Ratio
- 0.0106
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0106 outside [0.5, 1.5]
Detected 2026-03-06